{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:39:28Z","timestamp":1777354768431,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,9,29]],"date-time":"2011-09-29T00:00:00Z","timestamp":1317254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s10067-011-1856-5","type":"journal-article","created":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T06:14:48Z","timestamp":1317190488000},"page":"1555-1561","source":"Crossref","is-referenced-by-count":42,"title":["Heptavalent pneumococcal conjugate vaccine elicits similar antibody response as standard 23-valent polysaccharide vaccine in adult patients with RA treated with immunomodulating drugs"],"prefix":"10.1007","volume":"30","author":[{"given":"Meliha Crnkic","family":"Kapetanovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Roseman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6ran","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lennart","family":"Truedsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,29]]},"reference":[{"issue":"34","key":"1856_CR1","first-page":"1102","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","unstructured":"Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices (2010) Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep 59(34):1102\u20131106","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1856_CR2","unstructured":"Recommendations of the Swedish National Board of Health and Welfare. Pneumococcal Vaccination(1994). (Socialstyrelsens allm\u00e4nna r\u00e5d) SOSFS 1994:26. Vaccination mot pneumokocker. Available at http:\/\/www.socialstyrelsen.se\/sosfs\/1994-26"},{"issue":"567","key":"1856_CR3","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.3399\/bjgp09X472629","volume":"59","author":"Y Vinogradova","year":"2009","unstructured":"Vinogradova Y, Hippisley-Cox J, Coupland C (2009) Identification of new risk factors for pneumonia: population-based case\u2013control study. Br J Gen Pract 59(567):e329\u2013e338","journal-title":"Br J Gen Pract"},{"issue":"2","key":"1856_CR4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/ard.2008.089276","volume":"69","author":"JD Greenberg","year":"2010","unstructured":"Greenberg JD, Reed G, Kremer JM, Tindall E, Kavanaugh A, Zheng C, Bishai W, Hochberg MC, CORRONA Investigators (2010) Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry. Ann Rheum Dis 69(2):380\u2013386, Epub 2009 Apr 8","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1856_CR5","first-page":"CD000422","volume":"23","author":"SA Moberley","year":"2008","unstructured":"Moberley SA, Holden J, Tatham DP, Andrews RM (2008) Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 23(1):CD000422","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1856_CR6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1503\/cmaj.080734","volume":"180","author":"A Huss","year":"2009","unstructured":"Huss A, Scott P, Stuck AE, Trotter C, Egger M (2009) Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 180(1):48\u201358","journal-title":"CMAJ"},{"issue":"4","key":"1856_CR7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1086\/649839","volume":"201","author":"DM Musher","year":"2010","unstructured":"Musher DM, Manof SB, Liss C, McFetridge RD, Marchese RD, Bushnell B, Alvarez F, Painter C, Blum MD, Silber JL (2010) Safety and antibody response, including antibody persistence for 5\u00a0years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults. J Infect Dis 201(4):516\u2013524","journal-title":"J Infect Dis"},{"issue":"2","key":"1856_CR8","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/ije\/26.2.420","volume":"26","author":"U Sankilampi","year":"1997","unstructured":"Sankilampi U, Isoaho R, Bloigu A, Kivel\u00e4 SL, Leinonen M (1997) Effect of age, sex and smoking habits on pneumococcal antibody levels in an elderly population. Int J Epidemiol 26(2):420\u2013427","journal-title":"Int J Epidemiol"},{"key":"1856_CR9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/rheumatology\/kei193","volume":"45","author":"MC Kapetanovic","year":"2006","unstructured":"Kapetanovic MC, Saxne T, Sj\u00f6holm A, Truedsson L, J\u00f6nsson G, Geborek P (2006) Influence of methotrexate, TNF-blocker and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology 45:106\u2013111","journal-title":"Rheumatology"},{"key":"1856_CR10","unstructured":"Prevenar. Information fr\u00e5n L\u00e4kemedelsverket (Medical Products Agency, Sweden) 2001;12(4). ISSN 1101\u20137104. Available at http:\/\/www.lakemedelsverket.se"},{"issue":"36","key":"1856_CR11","first-page":"893","volume":"54","author":"CDC","year":"2005","unstructured":"CDC (2005) Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive disease\u2014United States, 1998\u20132003. MMWR Morb Mortal Wkly Rep 54(36):893\u2013897","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"16","key":"1856_CR12","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","volume":"294","author":"CA Lexau","year":"2005","unstructured":"Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, Harrison LH, Schaffner W, Reingold A, Bennett NM, Hadler J, Cieslak PR, Whitney CG, Active Bacterial Core Surveillance Team (2005) Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294(16):2043\u20132051","journal-title":"JAMA"},{"key":"1856_CR13","unstructured":"Kapetanovic MC, Roseman C, Saxne T, J\u00f6nsson G, Truedsson L, Geborek P (2011) Methotrexate but not TNF-blockers reduces immune response following pneumococcal vaccination using 7-valent conjugate pneumococcal vaccine (Prevenar\u00ae) in adult patients with established arthritis. Arthritis Rheum (in press)"},{"key":"1856_CR14","unstructured":"WHO. Training manual for Streptococcus pneumoniae serotype specific IgG (PN PS ELISA). Available at: http:\/\/www.vaccine.uab.edu\/ELISA%20Protocol.pdf . Accessed 30 Sept 2010"},{"issue":"5","key":"1856_CR15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3201\/eid1605.091223","volume":"16","author":"GD Rodenburg","year":"2010","unstructured":"Rodenburg GD, de Greeff SC, Jansen AG, de Melker HE, Schouls LM, Hak E, Spanjaard L, Sanders EA, van der Ende A (2010) Effects of pneumococcal conjugate vaccine 2\u00a0years after its introduction, the Netherlands. Emerg Infect Dis 16(5):816\u2013823","journal-title":"Emerg Infect Dis"},{"issue":"9546","key":"1856_CR16","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","volume":"368","author":"CG Whitney","year":"2006","unstructured":"Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, Nyquist AC, Gershman KA, Vazquez M, Bennett NM, Reingold A, Thomas A, Glode MP, Zell ER, Jorgensen JH, Beall B, Schuchat A (2006) Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 368(9546):1495\u20131502","journal-title":"Lancet"},{"issue":"Pt 1","key":"1856_CR17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1099\/jmm.0.023135-0","volume":"60","author":"D Foster","year":"2011","unstructured":"Foster D, Walker AS, Paul J, Griffiths D, Knox K, Peto TE, Crook DW, Oxford Invasive Pneumococcal Surveillance Group (2011) Reduction in invasive pneumococcal disease following implementation of the conjugate vaccine in the Oxfordshire region, England. J Med Microbiol 60(Pt 1):91\u201397, Epub 2010 Sep 23","journal-title":"J Med Microbiol"},{"issue":"10","key":"1856_CR18","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.vaccine.2008.11.098","volume":"27","author":"I Ridda","year":"2009","unstructured":"Ridda I, Macintyre CR, Lindley R, Gao Z, Sullivan JS, Yuan FF, McIntyre PB (2009) Immunological responses to pneumococcal vaccine in frail older people. Vaccine 27(10):1628\u20131636, Epub 2008 Dec 17","journal-title":"Vaccine"},{"issue":"1","key":"1856_CR19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/IAI.65.1.242-247.1997","volume":"65","author":"MA Shelly","year":"1997","unstructured":"Shelly MA, Jacoby H, Riley GJ, Graves BT, Pichichero M, Treanor JJ (1997) Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults. Infect Immun 65(1):242\u2013247","journal-title":"Infect Immun"},{"issue":"7","key":"1856_CR20","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1086\/529142","volume":"46","author":"A Roux de","year":"2008","unstructured":"de Roux A, Schm\u00f6le-Thoma B, Siber GR, Hackell JG, Kuhnke A, Ahlers N, Baker SA, Razmpour A, Emini EA, Fernsten PD, Gruber WC, Lockhart S, Burkhardt O, Welte T, Lode HM (2008) Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis 46(7):1015\u20131023","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1856_CR21","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1164\/rccm.200903-0488OC","volume":"180","author":"MT Dransfield","year":"2009","unstructured":"Dransfield MT, Nahm MH, Han MK, Harnden S, Criner GJ, Martinez FJ, Scanlon PD, Woodruff PG, Washko GR, Connett JE, Anthonisen NR, Bailey WC, COPD Clinical Research Network (2009) Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 180(6):499\u2013505, Epub 2009 Jun","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1856_CR22","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1172\/JCI117394","volume":"94","author":"AP Wessels Cope","year":"1994","unstructured":"Wessels Cope AP, Londei M, Chu NR, Cohen SB, Elliott MJ, Brennan FM, Maini RN, Feldmann M (1994) Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor\/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis. J Clin Invest 94(2):749\u2013760","journal-title":"J Clin Invest"},{"issue":"3","key":"1856_CR23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/rheumatology\/kem279","volume":"47","author":"JA Wessels","year":"2008","unstructured":"Wessels JA, Huizinga TW, Guchelaar HJ (2008) Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. Rheumatology (Oxford) 47(3):249\u2013255, Epub 2007 Nov 28","journal-title":"Rheumatology (Oxford)"},{"key":"1856_CR24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-4933-7-7","volume":"7","author":"J Ongr\u00e1di","year":"2010","unstructured":"Ongr\u00e1di J, K\u00f6vesdi V (2010) Factors that may impact on immunosenescence: an appraisal. Immun Ageing 7:7","journal-title":"Immun Ageing"},{"issue":"5","key":"1856_CR25","first-page":"952","volume":"34","author":"S Visvanathan","year":"2007","unstructured":"Visvanathan S, Keenan GF, Baker DG, Levinson AI, Wagner CL (2007) Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone. J Rheumatol 34(5):952\u2013957","journal-title":"J Rheumatol"},{"issue":"3","key":"1856_CR26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1086\/649872","volume":"50","author":"ZB Harboe","year":"2010","unstructured":"Harboe ZB, Benfield TL, Valentiner-Branth P, Hjuler T, Lambertsen L, Kaltoft M, Krogfelt K, Slotved HC, Christensen JJ, Konradsen HB (2010) Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin Infect Dis 50(3):329\u2013337","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-011-1856-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-011-1856-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-011-1856-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T04:28:20Z","timestamp":1593059300000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-011-1856-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,29]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1856"],"URL":"https:\/\/doi.org\/10.1007\/s10067-011-1856-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,29]]}}}